“In the United States, pharmaceutical companies have built a system which supports high costs for H.I.V. drugs. But that may be starting to change.”
For more, click here.
H.I.V. Drugs Cost $75 in Africa, $39,000 in the U.S. Does It Matter?
[From New York Times, Sept 18, 2018]